LOFENA
Live / Registered — Registered (as of 04 Oct 2022)
What this means for you
Registered since 04 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90760598
- Registration number
- 6867812
- Mark type
- Stylized text
- Filed
- 08 Jun 2021
- Published for opposition
- 05 Apr 2022
- Registered
- 04 Oct 2022
- Attorney of record
- Timothy D. Pecsenye
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain associated with inflammation, chronic inflammatory disease of musculoskeletal system, post-traumatic inflammation of soft tissue and musculoskeletal system, pain in the spine, neuralgia, myalgia, arthralgia, pain and inflammation after surgery or injury, pain in gout, and migraine
Owner
- Carwin Pharmaceutical Associates, LLC, Hazlet, NJ, US
- Carwin Pharmaceutical Associates, LLC, Hazlet, NJ, US
- Carwin Pharmaceutical Associates, LLC, Hazlet, NJ, US
Prosecution history
- 04 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Jun 2022 — USE AMENDMENT FILED
- 27 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
- 31 May 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Apr 2022 — PUBLISHED FOR OPPOSITION
- 16 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Feb 2022 — ASSIGNED TO EXAMINER